There is no single safest drug for rheumatoid arthritis — safety depends on your health history, other medications, and how your body responds

When doctors talk about safety in rheumatoid arthritis treatment, they mean different things for different people. A drug that is safe for one person may carry real risks for another. The medications that work best for RA — biologics and conventional DMARDs (disease-modifying antirheumatic drugs) — all carry potential side effects, but they also prevent joint damage that would otherwise worsen over time. Your rheumatologist weighs the benefit of slowing disease against the specific risks you face based on your age, other conditions, infections you have had, and what you are already taking.

The goal is not to find a drug with zero risk. It is to find the drug that gives you the most disease control with side effects you and your doctor agree you can manage. That conversation should happen before you start any new RA medication, and it should happen again if side effects develop.

Key Takeaways

  • Conventional DMARDs like methotrexate have been used for decades and doctors know their side effect patterns well, but they require regular blood tests to monitor liver and kidney function.
  • Biologic drugs work faster and more precisely than conventional DMARDs but carry a higher risk of serious infection because they suppress specific parts of the immune system.
  • JAK inhibitors are newer oral drugs that fall between conventional DMARDs and biologics in terms of both effectiveness and infection risk.
  • Your personal safety profile depends on whether you have a history of tuberculosis, hepatitis, heart failure, or recurrent infections — conditions that rule out certain drugs entirely.
  • Blood tests before starting treatment and regular monitoring during treatment catch problems early and let your doctor adjust or switch medications if needed.

How conventional DMARDs compare to newer drugs

Methotrexate is the oldest and most commonly prescribed DMARD. It has been used for RA since the 1980s, so rheumatologists have decades of data on how it behaves in different patients. It is taken once a week by mouth or injection. The main safety concern is that it can damage the liver and kidneys over time, which is why you need blood tests every 8 to 12 weeks to check liver enzymes and kidney function. It can also lower your white blood cell count, making infection more likely. Methotrexate is not safe during pregnancy.

Other conventional DMARDs — sulfasalazine, leflunomide, and hydroxychloroquine — work similarly to methotrexate but are used less often now because biologic drugs are more effective. They still require regular blood work and carry risks of liver damage or low blood counts, but the pattern of side effects is well understood.

The advantage of conventional DMARDs is that doctors have treated millions of patients with them and know what to watch for. The disadvantage is that they work more slowly than biologics — it can take weeks or months to see improvement — and they do not work well enough for many people with moderate to severe RA.

What makes biologic drugs different and riskier

Biologic drugs target specific parts of the immune system that drive RA inflammation. They work faster and more powerfully than conventional DMARDs. Common biologics include TNF inhibitors (infliximab, adalimumab, etanercept), IL-6 inhibitors (tocilizumab), and B-cell inhibitors (rituximab). They are given by injection or infusion, usually every 2 to 4 weeks.

The main safety concern with biologics is serious infection. Because these drugs suppress the immune system in a targeted way, your body becomes less able to fight off bacteria, viruses, and fungi. Tuberculosis is a particular concern — you must be tested for TB before starting a biologic, and if you have latent TB, you need preventive antibiotics first. Fungal infections, pneumonia, and reactivation of hepatitis B are also possible. For this reason, biologics are not safe if you have active tuberculosis, untreated hepatitis B, or a history of serious infections you have not fully recovered from.

Biologics also carry a small increased risk of certain cancers, heart failure, and nervous system problems, though these are rare. Regular monitoring with blood tests and imaging helps catch problems early. Unlike conventional DMARDs, biologics do not require the same frequent blood work, but your doctor will still check your blood counts and liver function periodically.

JAK inhibitors: a middle ground between conventional and biologic drugs

JAK inhibitors are oral medications (baricitinib, tofacitinib, upadacitinib) that block specific enzymes involved in immune signaling. They are newer than conventional DMARDs but older than most biologics. They work faster than methotrexate but may not be quite as powerful as the strongest biologics, though this is still being studied.

JAK inhibitors carry infection risk similar to biologics — your immune system is suppressed, so serious infections are possible — but the risk may be slightly lower than with TNF inhibitors. They also carry a small increased risk of blood clots and heart problems, which is why they are not recommended if you have a history of stroke, heart attack, or blood clots. Like biologics, they require testing for TB before you start and regular blood work during treatment.

The advantage of JAK inhibitors is that they are pills you take at home, not injections or infusions. The disadvantage is that they are newer, so long-term safety data is still being collected. They are also more expensive than conventional DMARDs but usually less expensive than biologics.

Conditions that rule out certain drugs

Your medical history determines which drugs are actually safe for you, regardless of how safe they are in general. If you have any of the following, tell your rheumatologist before starting any new RA drug:

  • Active tuberculosis or latent TB without preventive treatment: Rules out all biologics and JAK inhibitors. Conventional DMARDs may be used with caution.
  • Untreated hepatitis B: Rules out biologics and JAK inhibitors. Methotrexate requires careful monitoring.
  • Heart failure: Some TNF inhibitors can worsen heart failure. IL-6 inhibitors may be safer. JAK inhibitors are not recommended.
  • History of blood clots or stroke: JAK inhibitors carry extra risk and are usually avoided.
  • Recurrent serious infections: All RA drugs suppress the immune system to some degree. If you have had multiple hospitalizations for infection, your rheumatologist may recommend the least immunosuppressive option or close monitoring with a specialist.
  • Pregnancy or planning pregnancy: Methotrexate and leflunomide are not safe. Some biologics and JAK inhibitors may be continued under close supervision, but this requires discussion with both your rheumatologist and obstetrician.

What blood tests and monitoring tell your doctor

Before you start any RA drug, your doctor will order baseline blood work: a complete blood count, liver and kidney function tests, and tests for TB, hepatitis B, and hepatitis C. These results establish your starting point and identify any conditions that would make a drug unsafe.

During treatment, the frequency of monitoring depends on the drug. With methotrexate, you typically have blood work every 8 to 12 weeks. With biologics and JAK inhibitors, blood work is usually done every 3 to 6 months. These tests check for low blood counts (which increase infection risk), liver damage, kidney damage, and other problems. If results show a problem, your doctor may lower the dose, switch to a different drug, or add another medication to protect your organs.

You should also report new symptoms to your rheumatologist right away: fever, chills, persistent cough, shortness of breath, unusual bruising, or signs of infection. These can be early warnings that the drug is not safe for you at that dose.

How to talk with your rheumatologist about safety

Before starting a new RA drug, ask your doctor these specific questions:

  • Based on my health history, which drugs are safest for me and which ones are ruled out?
  • What are the most common side effects I should expect, and which ones mean I should call you right away?
  • How often will I need blood work, and what are you checking for?
  • If I develop a side effect, can we switch to a different drug, or will I need to stop treatment?
  • Are there any foods, supplements, or other medications I should avoid while taking this drug?

If your doctor recommends a drug that concerns you, ask why that drug is the best choice for your specific situation rather than another option. A good answer will reference your test results, your disease severity, or your medical history — not just "it is the safest" or "most people do well on it." Safety is personal.

When to seek care during treatment

Contact your rheumatologist or go to urgent care if you develop any of these while taking an RA drug:

  • Fever above 100.4°F that lasts more than a few hours
  • Persistent cough, shortness of breath, or chest pain
  • Unusual bruising, bleeding gums, or blood in urine or stool
  • Severe abdominal pain or yellowing of skin or eyes
  • Swelling in the legs, chest pain, or shortness of breath (possible blood clot)
  • New rash, especially if it spreads or blisters

These symptoms do not always mean the drug is unsafe for you — they may be unrelated or manageable with a dose adjustment — but your doctor needs to know about them quickly. Do not wait for your next scheduled appointment.

Frequently Asked Questions

Is methotrexate safer than biologics?

Methotrexate has a longer track record, so doctors know its side effects well. But it is not necessarily safer overall — it still suppresses the immune system and can damage the liver. Biologics work faster and more powerfully, which means better disease control for many people, but they carry a higher infection risk. Which is safer for you depends on your specific health history and how your body responds.

Can I stop taking my RA drug if I am worried about side effects?

Do not stop on your own. If you are having side effects, call your rheumatologist. Many side effects improve with a lower dose or can be managed with other medications. If the drug truly is not safe for you, your doctor can switch you to something else. Stopping RA treatment without a plan usually leads to flare-ups and joint damage.

Do I need blood work forever if I take an RA drug?

Yes, as long as you are taking the medication. The frequency may decrease over time if your disease is stable and you are tolerating the drug well, but your doctor will always need periodic checks to catch problems early. Once you stop the drug, blood work can usually stop too, though your doctor may recommend a final check a few weeks after stopping.

What if I have had a serious infection in the past — does that mean I cannot take biologics?

Not necessarily, but it depends on what the infection was and whether it has fully resolved. If you had pneumonia or a urinary tract infection years ago and recovered completely, biologics may still be safe. If you have had tuberculosis, fungal infections, or infections that required hospitalization, you need to discuss this carefully with your rheumatologist. Some infections rule out biologics entirely; others require preventive treatment first.

Are there any RA drugs with no side effects?

No. All RA drugs work by suppressing inflammation or the immune system, and that suppression carries risks. The goal is not zero risk — it is the right balance between controlling your disease and managing side effects you can live with. For many people, the benefit of stopping joint damage outweighs the risks of the medication.